<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Microbiol</journal-id><journal-title>BMC Microbiology</journal-title><issn pub-type="epub">1471-2180</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2180-7-99</article-id><article-id pub-id-type="pmid">17986343</article-id><article-id pub-id-type="doi">10.1186/1471-2180-7-99</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Subtle genetic changes enhance virulence of methicillin resistant and sensitive <italic>Staphylococcus aureus</italic></article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Highlander</surname><given-names>Sarah K</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>sarahh@bcm.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Hult&#x000e9;n</surname><given-names>Kristina G</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>khulten@bcm.edu</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Qin</surname><given-names>Xiang</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>xqin@bcm.edu</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Jiang</surname><given-names>Huaiyang</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>hjiang1@bcm.edu</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Yerrapragada</surname><given-names>Shailaja</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>yerrapra@bcm.edu</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Mason</surname><given-names>Edward O</given-names><suffix>Jr</suffix></name><xref ref-type="aff" rid="I2">2</xref><email>emason@bcm.edu</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Shang</surname><given-names>Yue</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>shang@bcm.edu</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Williams</surname><given-names>Tiffany M</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>tmwillia@bcm.edu</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Fortunov</surname><given-names>R&#x000e9;gine M</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>fortunov@bcm.edu</email></contrib><contrib id="A10" contrib-type="author"><name><surname>Liu</surname><given-names>Yamei</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>yamei.liu@mail.uh.edu</email></contrib><contrib id="A11" contrib-type="author"><name><surname>Igboeli</surname><given-names>Okezie</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>igboeli@bcm.edu</email></contrib><contrib id="A12" contrib-type="author"><name><surname>Petrosino</surname><given-names>Joseph</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jpetrosi@bcm.edu</email></contrib><contrib id="A13" contrib-type="author"><name><surname>Tirumalai</surname><given-names>Madhan</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>tmad@nsm.uh.edu</email></contrib><contrib id="A14" contrib-type="author"><name><surname>Uzman</surname><given-names>Akif</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>uzmana@uhd.edu</email></contrib><contrib id="A15" contrib-type="author"><name><surname>Fox</surname><given-names>George E</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>fox@uh.edu</email></contrib><contrib id="A16" contrib-type="author"><name><surname>Cardenas</surname><given-names>Ana Maria</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>acardena@bcm.edu</email></contrib><contrib id="A17" contrib-type="author"><name><surname>Muzny</surname><given-names>Donna M</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>donnam@bcm.edu</email></contrib><contrib id="A18" contrib-type="author"><name><surname>Hemphill</surname><given-names>Lisa</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>hemphill@bcm.edu</email></contrib><contrib id="A19" contrib-type="author"><name><surname>Ding</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>yding@bcm.edu</email></contrib><contrib id="A20" contrib-type="author"><name><surname>Dugan</surname><given-names>Shannon</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>sdugan@bcm.edu</email></contrib><contrib id="A21" contrib-type="author"><name><surname>Blyth</surname><given-names>Peter R</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>pblyth@bcm.edu</email></contrib><contrib id="A22" contrib-type="author"><name><surname>Buhay</surname><given-names>Christian J</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>cbuhay@bcm.edu</email></contrib><contrib id="A23" contrib-type="author"><name><surname>Dinh</surname><given-names>Huyen H</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>hdinh@bcm.edu</email></contrib><contrib id="A24" contrib-type="author"><name><surname>Hawes</surname><given-names>Alicia C</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>ahawes@bcm.edu</email></contrib><contrib id="A25" contrib-type="author"><name><surname>Holder</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>mholder@bcm.edu</email></contrib><contrib id="A26" contrib-type="author"><name><surname>Kovar</surname><given-names>Christie L</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>ckovar@bcm.edu</email></contrib><contrib id="A27" contrib-type="author"><name><surname>Lee</surname><given-names>Sandra L</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>sllee@bcm.edu</email></contrib><contrib id="A28" contrib-type="author"><name><surname>Liu</surname><given-names>Wen</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>wliu@bcm.edu</email></contrib><contrib id="A29" contrib-type="author"><name><surname>Nazareth</surname><given-names>Lynne V</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>lynnen@bcm.edu</email></contrib><contrib id="A30" contrib-type="author"><name><surname>Wang</surname><given-names>Qiaoyan</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>qiaoyanw@bcm.edu</email></contrib><contrib id="A31" contrib-type="author"><name><surname>Zhou</surname><given-names>Jianling</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>zhou@bcm.edu</email></contrib><contrib id="A32" contrib-type="author"><name><surname>Kaplan</surname><given-names>Sheldon L</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>skaplan@bcm.edu</email></contrib><contrib id="A33" contrib-type="author"><name><surname>Weinstock</surname><given-names>George M</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><xref ref-type="aff" rid="I4">4</xref><email>gwstock@bcm.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA</aff><aff id="I2"><label>2</label>Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA</aff><aff id="I3"><label>3</label>Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA</aff><aff id="I4"><label>4</label>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA</aff><aff id="I5"><label>5</label>University of Houston-Downtown, Houston, TX, USA</aff><aff id="I6"><label>6</label>University of Houston, Houston, TX, USA</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>6</day><month>11</month><year>2007</year></pub-date><volume>7</volume><fpage>99</fpage><lpage>99</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2180/7/99"/><history><date date-type="received"><day>14</day><month>6</month><year>2007</year></date><date date-type="accepted"><day>6</day><month>11</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Highlander et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Highlander et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Highlander K Sarah sarahh@bcm.edu </dc:author><dc:title> Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Microbiology 7(1): 99-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2180(2007)7:1&#x0003c;99&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2180</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Community acquired (CA) methicillin-resistant <italic>Staphylococcus aureus </italic>(MRSA) increasingly causes disease worldwide. USA300 has emerged as the predominant clone causing superficial and invasive infections in children and adults in the USA. Epidemiological studies suggest that USA300 is more virulent than other CA-MRSA. The genetic determinants that render virulence and dominance to USA300 remain unclear.</p></sec><sec><title>Results</title><p>We sequenced the genomes of two pediatric USA300 isolates: one CA-MRSA and one CA-methicillin susceptible (MSSA), isolated at Texas Children's Hospital in Houston. DNA sequencing was performed by Sanger dideoxy whole genome shotgun (WGS) and 454 Life Sciences pyrosequencing strategies. The sequence of the USA300 MRSA strain was rigorously annotated. In USA300-MRSA 2658 chromosomal open reading frames were predicted and 3.1 and 27 kilobase (kb) plasmids were identified. USA300-MSSA contained a 20 kb plasmid with some homology to the 27 kb plasmid found in USA300-MRSA. Two regions found in US300-MRSA were absent in USA300-MSSA. One of these carried the arginine deiminase operon that appears to have been acquired from <italic>S. epidermidis</italic>. The USA300 sequence was aligned with other sequenced <italic>S. aureus </italic>genomes and regions unique to USA300 MRSA were identified.</p></sec><sec><title>Conclusion</title><p>USA300-MRSA is highly similar to other MRSA strains based on whole genome alignments and gene content, indicating that the differences in pathogenesis are due to subtle changes rather than to large-scale acquisition of virulence factor genes. The USA300 Houston isolate differs from another sequenced USA300 strain isolate, derived from a patient in San Francisco, in plasmid content and a number of sequence polymorphisms. Such differences will provide new insights into the evolution of pathogens.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Community acquired methicillin-resistant <italic>Staphylococcus aureus </italic>(CA-MRSA) infections are increasing worldwide [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Although the emergence is concurrent, genetically distinct clones have been reported from different continents [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. In the United States, two clones, USA300 and USA400 have been associated with the majority of CA-MRSA infections [<xref ref-type="bibr" rid="B7">7</xref>]. However, USA300 is currently being reported as the predominant cause of both adult and pediatric CA-MRSA infections in many states [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B12">12</xref>]. At Texas Children's Hospital (TCH) in Houston, Texas, we have observed a continuous increase of CA-<italic>S. aureus </italic>infections, predominantly CA-MRSA, in a prospective surveillance study initiated in 2001 [<xref ref-type="bibr" rid="B13">13</xref>]. Skin and soft tissue infections (SSTI) represented 94%; 58% of SSTI patients were hospitalized. We have also reported an increased number and severity of invasive cases, <italic>e.g</italic>. complicated pneumonia, osteomyelitis, pyomyositis, myositis and severe sepsis syndrome associated with the predominance of clone USA300 [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. Similar observations have been described at other institutions across the United States [<xref ref-type="bibr" rid="B19">19</xref>]. Recent reports suggest that USA300 is more virulent than other MRSA strains [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. USA300 is genetically related to the nosocomial MRSA strain COL, which emerged in the 1960s in Europe following the introduction of methicillin. Both of these strains are likely descendents of a methicillin-susceptible ancestral strain [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>].</p><p>Approximately 75% of the CA-<italic>S. aureus </italic>strains at TCH are MRSA; 95% of these are USA300. In contrast to the homogeneity of CA-MRSA, CA methicillin-susceptible <italic>S. aureus </italic>(MSSA) from the same population are more heterogeneous; USA300 represented approximately 25% of these strains between 2000&#x02013;2002 [<xref ref-type="bibr" rid="B9">9</xref>]. We continue to note a greater absolute increase in the number of CA-MRSA isolates, being virtually all USA300-MR, compared with CA-MSSA among children evaluated at TCH (Figures <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Histogram of the prevalence of community-acquired MR and MS strains of <italic>S. aureus </italic>at TCH over a four-year study. All cases are shown in red, MR cases in green and MS cases in purple.</p></caption><graphic xlink:href="1471-2180-7-99-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p>PFGE of <italic>Sma </italic>I-digested USA300-HOU-MR and USA300-HOU-MS. Replicates of MR (left) and MS (right) profiles are shown. Molecular weight markers are shown in kilobases.</p></caption><graphic xlink:href="1471-2180-7-99-2"/></fig><p>At the time of this writing, the complete genomes of eleven MRSA and MSSA clinical strains, of both community and hospital origin, plus a bovine <italic>S. aureus </italic>strain have been deposited in the GenBank database. Recently, the genome sequence of a multi-resistant USA300-MR isolate (FPR3757) from an abscess of an HIV-positive intravenous drug user was reported [<xref ref-type="bibr" rid="B24">24</xref>]. We present the sequence of a USA300-MR isolate from an otherwise healthy pediatric patient (USA300-HOU) and compare it to the genomes of FPR3757 and a USA300-MS isolate from TCH. We postulate that comparison of the genomes of USA300-MR and USA300-MS will provide clues to the enhanced ability of USA300-HOU-MR to spread and cause infections among children compared to other <italic>S. aureus </italic>clones circulating in Houston.</p></sec><sec><title>Results</title><sec><title>Features of the USA300-HOU-MR genome</title><p>The USA300-HOU-MR genome is 2,872,915 bp in length and was annotated to encode 2658 proteins, 59 tRNAs (plus one pseudogene), 5 ribosomal RNA operons and 21 non-coding RNAs (Table <xref ref-type="table" rid="T1">1</xref>). A circular representation of the sequenced genome is shown in Figure <xref ref-type="fig" rid="F3">3</xref>. To identify DNA regions unique to USA300-HOU-MR, two-way BLASTN was performed against each of the other complete staphylococcal genomes (Figure <xref ref-type="fig" rid="F4">4</xref>). USA300-HOU-MR carries the staphylococcal cassette chromosome <italic>mec </italic>(SCC<italic>mec</italic>) type IVa methicillin resistance cassette. In addition to SCC<italic>mec </italic>IVa, the strain also contains a ca. 31 kb region of DNA from 57860 to 88845 that is unique only to USA300-HOU-MR, USA300-FPR3757 and to <italic>S. epidermidis </italic>ATCC12228 (Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>) [<xref ref-type="bibr" rid="B25">25</xref>]. This region maps immediately downstream of SCC<italic>mec </italic>and the entire element (34173 to 88845) is flanked by an IS<italic>431mec </italic>transposase gene and a possible transposase gene. The region downstream of SCC<italic>mec </italic>carries genes encoding an arginine deiminase operon, a Crp family transcriptional regulator, an APC family arginine/ornithine antiporter, and an arginine repressor. In USA300-FPR3757, this region is called ACME, for arginine catabolic mobile element [<xref ref-type="bibr" rid="B24">24</xref>]. Downstream of the arginine element we also annotated genes encoding a universal stress protein, a lysophospholipase, a possible S-adenosyl-L-methionine (SAM)-dependent methyltransferase, an ABC superfamily ATP binding cassette transporter, a P-ATPase copper transporter, a possible lipoprotein and an integrase. The ABC transporter proteins had top BLAST hits to nickel, dipeptide or oligopeptide transporters in other species and it was annotated as an oligopeptide transporter by Diep, et al. [<xref ref-type="bibr" rid="B24">24</xref>]. ClustalW analyses of the individual components of these transporters indicated a clustering of nickel-specific sequences with those from USA300-HOU-MR (data not shown). Thus, we believe that this transporter is likely involved in nickel acquisition. InterProScan, PFP and PSORTB, SecretomeP2.0 were used to augment the annotation data obtained by BLASTP and CDD. Based on this analysis, the SCC<italic>mec</italic>-ACME region encodes four non-classically secreted proteins and three other extracellular proteins. The region also encodes a possible endonuclease, possible tRNA ligases, RNA polymerases and a primase. We also identified a number of ORFs that were not annotated in USA300-FPR3757; these were hypothetical or conserved hypothetical proteins.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Riboswitches and small non-coding RNAs in USA300-HOU-MR</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Start</bold></td><td align="left"><bold>Stop</bold></td><td align="left"><bold>Definition</bold></td></tr></thead><tbody><tr><td align="left"><bold>Riboswitches</bold></td><td></td><td></td></tr><tr><td align="right">1,556,144</td><td align="right">1,556,024</td><td align="left">FMN riboswitch</td></tr><tr><td align="right">1,899,283</td><td align="right">1,899,148</td><td align="left">FMN riboswitch</td></tr><tr><td align="right">1,653,467</td><td align="right">1,653,370</td><td align="left">GcvT riboswitch</td></tr><tr><td align="right">2,272,812</td><td align="right">2,272,596</td><td align="left">GlmS riboswitch</td></tr><tr><td align="right">1,430,494</td><td align="right">1,430,669</td><td align="left">lysine riboswitch</td></tr><tr><td align="right">1,783,037</td><td align="right">1,782,862</td><td align="left">lysine riboswitch</td></tr><tr><td align="right">436,036</td><td align="right">436,135</td><td align="left">purine riboswitch</td></tr><tr><td align="right">893,057</td><td align="right">893,160</td><td align="left">SAM riboswitch</td></tr><tr><td align="right">1,025,974</td><td align="right">1,026,102</td><td align="left">YybP-YkoY riboswitch</td></tr><tr><td></td><td></td><td></td></tr><tr><td align="left"><bold>Small ncRNAs</bold></td><td></td><td></td></tr><tr><td align="right">1,736,694</td><td align="right">1,736,363</td><td align="left">6S RNA</td></tr><tr><td align="right">508,051</td><td align="right">508,326</td><td align="left">bacterial signal recognition particle RNA</td></tr><tr><td align="right">1,930,023</td><td align="right">1,929,680</td><td align="left">noncoding RNA SprA</td></tr><tr><td align="right">1,946,423</td><td align="right">1,945,949</td><td align="left">noncoding RNA SprB</td></tr><tr><td align="right">1,959,339</td><td align="right">1,958,106</td><td align="left">noncoding RNA SprC</td></tr><tr><td align="right">1,958,812</td><td align="right">1,958,861</td><td align="left">noncoding RNA SprC</td></tr><tr><td align="right">2,087,533</td><td align="right">2,086,851</td><td align="left">noncoding RNA SprD</td></tr><tr><td align="right">2,088,540</td><td align="right">2,089,062</td><td align="left">noncoding RNA SprE</td></tr><tr><td align="right">2,090,767</td><td align="right">2,090,977</td><td align="left">noncoding RNA SprF/SprG</td></tr><tr><td align="right">1,516,390</td><td align="right">1,515,994</td><td align="left">ribonuclease P (RNase P)</td></tr><tr><td align="right">2,147,378</td><td align="right">2,147,086</td><td align="left">RNAIII</td></tr><tr><td align="right">868,423</td><td align="right">868,737</td><td align="left">tmRNA SsrA</td></tr></tbody></table></table-wrap><fig position="float" id="F3"><label>Figure 3</label><caption><p>Chromosomal map of USA300-HOU-MR with landmarks indicating the SCC<italic>mec</italic>-ACME region (outer circle, green), pathogenicity islands (outer circle, light blue), prophage (outer circle, lavender), the 13 kb insertion sequence (outer circle, orange), and two regions of sequence not found in USA300-HOU-MS (outer circle, yellow). ORFs on both strands are represented by the second circle and are colored according to functional categories as follows and as shown in the key: cell processes, tan; cell structure, violet; DNA replication and recombination, red; general metabolism, blue; regulation, green; transcription, yellow; translation, orange; transport, cyan; virulence, fuchsia; unknown, black. The third circle shows RNAs: rRNAs, blue; tRNAs, red; ncRNAs, green. The inner circle shows the location of SNPs between USA300-HOU-MR and FPR3757.</p></caption><graphic xlink:href="1471-2180-7-99-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p>Linear representation of BLASTN comparison of <italic>S. aureus </italic>strains to USA300-HOU-MR. Strains are listed on the y-axis and the x-axis shows the USA300-HOU-MR coordinates. Bars represent regions of at least 50 bp in length present in USA300-HOU-MR but absent in the other strains.</p></caption><graphic xlink:href="1471-2180-7-99-4"/></fig></sec><sec><title>Pathogenicity islands and prophages</title><p>More than fifteen different pathogenicity islands have been identified in the sequenced <italic>S. aureus </italic>genomes [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. SaPIs are mobile genetic elements that carry about half of the known <italic>S. aureus </italic>toxin or virulence factor genes, and while strains contain different combinations of the islands, no strain appears to carry more than one copy of each type [<xref ref-type="bibr" rid="B27">27</xref>]. USA300-HOU-MR contains six, SaPI5, SaPIm4, SaPI6&#x00394;, <italic>v</italic>Sa&#x003b1;, <italic>v</italic>Sa&#x003b2;, and <italic>v</italic>Sa&#x003b3;. These encode enterotoxins, extotoxins and serine proteases as well as leukotoxin, hemolysin, exfoliatin, and epidermin (Figure <xref ref-type="fig" rid="F3">3</xref> and Table <xref ref-type="table" rid="T2">2</xref>). MW2, another community-acquired MRSA isolate contains the same complement of islands, while, COL, Mu50 and RF122 contain six islands each, though in different combinations.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Pathogenicity islands in completed genomes of <italic>S. aureus</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>ISLAND</bold></td><td align="center"><bold>VIRULENCE GENE PRODUCTS</bold></td><td align="center"><bold>USA300 MRSA</bold></td><td align="center"><bold>Newman</bold></td><td align="center"><bold>NCTC 8325</bold></td><td align="center"><bold>COL</bold></td><td align="center"><bold>MW2</bold></td><td align="center"><bold>MSSA 476</bold></td><td align="center"><bold>N315</bold></td><td align="center"><bold>Mu50</bold></td><td align="center"><bold>JH1</bold></td><td align="center"><bold>JH9</bold></td><td align="center"><bold>RF122</bold></td><td align="center"><bold>MRSA 252</bold></td></tr></thead><tbody><tr><td align="center">SaPI1</td><td align="left">TSST, SEK, SEL, Ear</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SaPI2</td><td align="left">TSST, exfoliatin</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SaPI3</td><td align="left">SEB, SEK, SEQ, Ear</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SaPI4</td><td align="left">None</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td></tr><tr><td align="center">SaPI5</td><td align="left">SEK, SEQ, Ear</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SaPIbov1</td><td align="left">TSST, SEK, SEL</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td></tr><tr><td align="center">SaPIbov2</td><td align="left">Bap adhesin</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SaPIm4</td><td align="left">ferrichrome transporter</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">-</td></tr><tr><td align="center">SaPImw2</td><td align="left">Ear, SEC4, SEL2</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SaPIn1/m1</td><td align="left">TSST, SEL, SEC3</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">SaPI122</td><td align="left">multidrug exporter</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">+</td><td align="center">-</td></tr><tr><td align="center">SaPI6&#x00394;</td><td align="left">None</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td><td align="center">-</td></tr><tr><td align="center">&#x003bd;Sa&#x003b1;</td><td align="left">SET exotoxins, lipoproteins</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td></tr><tr><td align="center">&#x003bd;Sa&#x003b2;</td><td align="left">serine proteases, leukotoxin D &#x00026; E, enterotoxins, epidermin</td><td align="center">+<sup>a</sup></td><td align="center">+<sup>a</sup></td><td align="center">+<sup>a</sup></td><td align="center">+<sup>a</sup></td><td align="center">+<sup>a</sup></td><td align="center">+<sup>a, b</sup></td><td align="center">+<sup>c</sup></td><td align="center">+<sup>c</sup></td><td align="center">+<sup>c</sup></td><td align="center">+<sup>c</sup></td><td align="center">+</td><td align="center">+<sup>b</sup></td></tr><tr><td align="center">&#x003bd;Sa&#x003b3;</td><td align="left">SET exotoxins, exfoliatin, alpha-hemolysin</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center">+</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>No enterotoxin genes</p><p><sup>b</sup>No leukotoxin genes</p><p><sup>c</sup>No epidermin genes</p></table-wrap-foot></table-wrap><p>USA300-HOU-MR carries two complete prophage sequences, &#x003c6;SLT-USA300 and &#x003c6;&#x003b2;C-USA300. Prophage remnants also occur within pathogenicity island SaPI5. The &#x003c6;SLT-USA300 sequence is 98% identical to the 46139 bp &#x003c6;SLT sequence [<xref ref-type="bibr" rid="B28">28</xref>], excepting gaps greater than 500 bp. These gaps represent regions in USA300 encoding a helicase and virulence-associated protein E, two DNA polymerases, and two prophage regulatory proteins. The prophage carries the Panton-Valentine leukocidin genes <italic>lukS-PV </italic>and <italic>lukF-PV</italic>. By PHYLIP analysis, the &#x003c6;SLT-USA300 sequence is most similar to the prophages in MW2 and clinical strain A980470 (phiSLT) [<xref ref-type="bibr" rid="B28">28</xref>] (Figure <xref ref-type="fig" rid="F5">5a</xref>). As observed for &#x003c6;SLT-A980470 and &#x003c6;-PVL, the &#x003c6;SLT-USA300 attachment site lies within a conserved hypothetical protein gene [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. The second prophage, &#x003c6;&#x003b2;C-USA300, is very similar to &#x003b2;-hemolysin-converting prophages identified in JH1, JH9, MRSA252, MSSA476, Mu50, MW2, N315, Newman, and NCTC8325 (Figure <xref ref-type="fig" rid="F5">5b</xref>). It is most similar to those found in JH1, JH9 and N315. In USA300, this prophage encodes staphylokinase, chemotaxis inhibitory protein and staphylococcal complement inhibitor; the order of these genes places it in immune evasion cluster (IEC) type B [<xref ref-type="bibr" rid="B30">30</xref>]. Unlike COL, USA300-HOU-MR lacks the L54&#x003b1;-like bacteriophage. As a result, the glycerol ester hydrolase, or <italic>geh </italic>lipase gene, which is disrupted in strains carrying the L54&#x003b1;-like prophage, is intact and presumed to be expressed.</p><fig position="float" id="F5"><label>Figure 5</label><caption><p>Boot-strapped phylogenetic trees of the prophages found in USA300-HOU-MR: a) phiSLT phage and b) phi&#x003b2;C family phage. The numbers on the branches indicate the number of times the sets co-partitioned after 100 iterations.</p></caption><graphic xlink:href="1471-2180-7-99-5"/></fig></sec><sec><title>Plasmids</title><p>Two plasmids were detected in USA300-HOU-MR (Figure <xref ref-type="fig" rid="F6">6a</xref> and <xref ref-type="fig" rid="F6">6b</xref>). The 3.1 kb plasmid, pUSA01-HOU, is identical to plasmid pUSA01 in USA300-FPR3757. It encodes a replication protein plus several conserved hypothetical proteins. The second larger plasmid, pUSA300-HOU-MR, appears to be a mosaic of parts of three plasmids: pN315 from <italic>S. aureus </italic>N315; pSR1 from <italic>S. aureus </italic>strain 01A103; and pSERP from <italic>S. epidermidis </italic>RP62A. The plasmid carries two recombinase genes and three IS<italic>431 </italic>transposase genes that may have played a role in fusion of the three elements. The replication region appears to be derived from pNF315B. pUSA300-HOU-MRSA encodes resistance to beta-lactam, macrolide, aminoglycoside, streptothricin (nourseothricin) and bacitracin antibiotics, consistent with the resistance pattern observed for USA300-HOU-MR (Table <xref ref-type="table" rid="T3">3</xref>), with the exception of nourseothricin. The streptothricin acetyltransferase and 3',5'-aminoglycoside transferase genes are adjacent and map between two IS<italic>431 </italic>transposase genes; long inverted repeats (<italic>ca</italic>. 700 bp) flank these genes. The repeats are most similar to the inverted repeats found in IS<italic>257 </italic>from <italic>S. epidermidis </italic>strain SK76 (Genbank <ext-link ext-link-type="gen" xlink:href="SEU40386">SEU40386</ext-link>) though similar repeats are found on a number of plasmids from both <italic>S. aureus </italic>and <italic>S. epidermidis</italic>. Thus, it appears that this region constitutes a compound transposon that could also be part of a larger element carrying the bacitracin transporter genes. A ca. 400 nt repeat (which is a subset of the ca 700 bp repeat) also occurs within the IS<italic>431 </italic>transpose genes at ca. 12.5 and 21 kb on the map. pUSA300-HOU-MR also encodes a cadmium transporter CadD and regulator CadX, and at least three additional predicted transcriptional regulators including BlaI and BlaR.</p><fig position="float" id="F6"><label>Figure 6</label><caption><p>Linear representations of circular plasmids observed in USA300-HOU-MR (a, b) and USA300-MS (c). Replication and regulatory genes are colored red, recombination/transposition genes are green, antibiotic/heavy metal/bacteriocin resistance genes are blue, other genes are white and hypothetical, conserved hypothetical (CHP) and staphylococcal conserved hypotheticals (SCHP) are colored grey. Horizontal bars indicate the regions of pUSA300-HOU-MR and pUSA300-HOU-MS having homology with other sequenced staphylococcal plasmids.</p></caption><graphic xlink:href="1471-2180-7-99-6"/></fig><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Antimicrobial susceptibilities of USA300-HOU-MR and USA300-HOU-MS</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Antibiotic</bold></td><td align="center" colspan="2"><bold>USA300-HOU-MR</bold></td><td align="center" colspan="2"><bold>USA300-HOU-MS</bold></td></tr><tr><td></td><td align="center"><bold>MIC</bold></td><td align="center"><bold>Phenotype</bold></td><td align="center"><bold>MIC</bold></td><td align="center"><bold>Phenotype</bold></td></tr></thead><tbody><tr><td align="left">Bacitracin</td><td align="center">&#x0003e;128</td><td align="center">R</td><td align="center">32</td><td align="center">S</td></tr><tr><td align="left">Cephalexin</td><td align="center">128</td><td align="center">R</td><td align="center">4</td><td align="center">S</td></tr><tr><td align="left">Cefazolin</td><td align="center">32</td><td align="center">R</td><td align="center">8</td><td align="center">S</td></tr><tr><td align="left">Cefotaxime</td><td align="center">&#x0003e;128</td><td align="center">R</td><td align="center">2</td><td align="center">S</td></tr><tr><td align="left">Ciprofloxacin</td><td align="center">0.5</td><td align="center">S</td><td align="center">0.25</td><td align="center">S</td></tr><tr><td align="left">Clarithromycin</td><td align="center">64</td><td align="center">R</td><td align="center">&#x0003c;0.125</td><td align="center">S</td></tr><tr><td align="left">Clindamycin</td><td align="center">0.06</td><td align="center">S</td><td align="center">0.06</td><td align="center">S</td></tr><tr><td align="left">Doxycycline</td><td align="center">&#x0003c;0.125</td><td align="center">S</td><td align="center">&#x0003c;0.125</td><td align="center">S</td></tr><tr><td align="left">Erythromycin</td><td align="center">64</td><td align="center">R</td><td align="center">&#x0003c;0.125</td><td align="center">S</td></tr><tr><td align="left">Gentamicin</td><td align="center">1</td><td align="center">S</td><td align="center">1</td><td align="center">S</td></tr><tr><td align="left">Kanamycin</td><td align="center">&#x0003e;128</td><td align="center">R</td><td align="center">4</td><td align="center">S</td></tr><tr><td align="left">Minocycline</td><td align="center">&#x0003c;0.125</td><td align="center">S</td><td align="center">&#x0003c;0.125</td><td align="center">S</td></tr><tr><td align="left">Nourseothricin</td><td align="center">8</td><td align="center">S</td><td align="center">4</td><td align="center">S</td></tr><tr><td align="left">Oxacillin</td><td align="center">128</td><td align="center">R</td><td align="center">1</td><td align="center">S</td></tr><tr><td align="left">Penicillin</td><td align="center">32</td><td align="center">R</td><td align="center">4</td><td align="center">R</td></tr><tr><td align="left">Rifampin</td><td align="center">&#x0003c;0.004</td><td align="center">S</td><td align="center">&#x0003c;0.004</td><td align="center">S</td></tr><tr><td align="left">Tetracycline</td><td align="center">&#x0003c;0.125</td><td align="center">S</td><td align="center">&#x0003c;0.125</td><td align="center">S</td></tr><tr><td align="left">Trimethoprim-Sulfamethoxazole</td><td align="center">&#x0003c;0.03/0.06</td><td align="center">S</td><td align="center">0.06/0.125</td><td align="center">S</td></tr><tr><td align="left">Vancomycin</td><td align="center">1</td><td align="center">S</td><td align="center">1</td><td align="center">S</td></tr></tbody></table><table-wrap-foot><p>MIC, minimum inhibitory concentration, &#x003bc;g/ml</p><p>R, resistant; S, susceptible</p></table-wrap-foot></table-wrap></sec><sec><title>Comparison of USA300-HOU-MR and USA300-FPR3757</title><p>We identified 14 insertions/deletions (indels) of greater than four bp between USA300- FPR3757 and USA300-HOU-MR (Table <xref ref-type="table" rid="T4">4</xref>). The most significant difference between the two strains is the location of a 13.4 kb insertion. In USA300-FPR3757, this region is inserted at nt 1,630,721 between a biotin carboxylase carrier protein gene, <italic>accB</italic>, and the elongation factor P gene <italic>efp</italic>. In USA300-HOU-MR, this same 13 kb segment of DNA is inserted at nt 680,375 within the <italic>snoA </italic>gene at the beginning of the staphylococcal <italic>nuo</italic>-like operon, which encodes an NADH dehydrogenase [<xref ref-type="bibr" rid="B31">31</xref>]. The 13 kb segment is also found in COL, at the same location as in USA300-FPR3757, and in MRSA252 between two bacteriophage protein genes. There is no homology flanking the insertions sites for this element and there are no obvious recombination sequences or repeats within the segment. The first gene in the segment encodes a frameshift of an IS<italic>SA1 </italic>transposase. The frameshift occurs in a poly adenine tract so sequence variation through slipped-strand mispairing is possible. Six of the proteins encoded by the 13 kb segment may be non-classically secreted proteins. Also encoded are a possible lipoprotein, a peptidoglycan hydrolase, a cell division protein, a GTP-binding protein, a replication protein and a possible actin-binding protein.</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Insertions and deletions between USA300-HOU-MR and FPR3757</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" colspan="2"><bold>Coordinates (nts)</bold></td><td></td><td></td></tr><tr><td align="left"><bold>USA300-HOU-MR</bold></td><td align="left"><bold>FPR3757</bold></td><td align="right"><bold>Length (nts)</bold></td><td align="left"><bold>Comments</bold></td></tr></thead><tbody><tr><td align="left">52999</td><td align="left">52999&#x02013;53053 insertion</td><td align="right">55</td><td align="left"><italic>mec</italic>IV<italic>a </italic>region</td></tr><tr><td align="left">128604</td><td align="left">128663&#x02013;128710 insertion</td><td align="right">47</td><td align="left">IgG binding protein A</td></tr><tr><td align="left">556303&#x02013;556952 insertion</td><td align="left">556410</td><td align="right">643</td><td align="left">rRNA</td></tr><tr><td align="left">680918&#x02013;694274 insertion</td><td align="left">680375</td><td align="right">13357</td><td align="left">plasmid-like sequences</td></tr><tr><td align="left">749056</td><td align="left">735156&#x02013;735224 insertion</td><td align="right">69</td><td align="left">hypothetical protein</td></tr><tr><td align="left">855698&#x02013;855815</td><td align="left">841867</td><td align="right">118</td><td align="left">hypothetical protein</td></tr><tr><td align="left">1644669</td><td align="left">1630721&#x02013;1644121 insertion</td><td align="right">13401</td><td align="left">plasmid-like sequences</td></tr><tr><td align="left">1857878&#x02013;1858036</td><td align="left">1857330</td><td align="right">159</td><td align="left">within repeat</td></tr><tr><td align="left">1995735</td><td align="left">1995030&#x02013;1995080 insertion</td><td align="right">51</td><td align="left">within repeat</td></tr><tr><td align="left">2031742</td><td align="left">2031088&#x02013;2031146 insertion</td><td align="right">59</td><td align="left">within repeats between 2 CHPs<sup>a</sup></td></tr><tr><td align="left">2179534</td><td align="left">2178939&#x02013;2179061 insertion</td><td align="right">123</td><td align="left">rRNA</td></tr><tr><td align="left">2179703</td><td align="left">2179232&#x02013;2179352 insertion</td><td align="right">121</td><td align="left">rRNA</td></tr><tr><td align="left">2295844</td><td align="left">2295493&#x02013;2295615 insertion</td><td align="right">123</td><td align="left">rRNA</td></tr><tr><td align="left">2296014</td><td align="left">2295786&#x02013;2295905 insertion</td><td align="right">120</td><td align="left">rRNA</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>CHP, conserved hypothetical protein</p></table-wrap-foot></table-wrap><p>An insertion of 159 bp in USA300-HOU-MR but not in USA300-FPR3757 occurs within a staphylococcal conserved hypothetical protein between 1857878 and 1858036. This insertion is a duplication of flanking sequence and maintains the reading frame of the protein. Another difference identified is a 47 bp region in USA300-FPR3757, within the repeated region of the IgG binding protein gene; again, these are absent from USA300-HOU. Additional short deletions in USA300-HOU-MR also occur within intergenic regions. Also of note is a frameshift in the gene encoding an AraC family transcriptional regulator in USA300 (742860&#x02013;745009). This frameshift is not observed in any of the other sequenced <italic>S. aureus </italic>strains. In addition, we identified a frameshift in the cell wall anchor protein gene (2623054&#x02013;2626400) not reported in the annotation of FP3757.</p><p>Comparison of the two USA300 sequences revealed 92 single nucleotide polymorphisms (SNPs) and two four bp. deletions (Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>). We also discovered 53 sequencing errors in the FPR357 sequence. Fifty-five of the SNPs map within ORFs, while 18 map within intergenic regions (this is consistent with the fact that 80% of the genome is coding sequence) and 7 map within rRNA sequences. Twenty-one of the changes within reading frames are synonymous, 34 are non-synonymous and 7 caused frameshifts. Two of the SNPs may explain differences in antibiotic susceptibility. One, a T (FPR357) to C (HOU) change in the <italic>gyrA </italic>gene causes a leucine to serine change at amino acid 84. The serine-containing GyrA protein confers resistance to ciprofloxacin (FPR357), while leucine confers the wild-type, susceptible phenotype (HOU, Table <xref ref-type="table" rid="T2">2</xref>) [<xref ref-type="bibr" rid="B32">32</xref>]. A second SNP presumed to be involved in fluoroquinolone resistance maps within the topoisomerase IV <italic>parC </italic>gene. Here, the USA300-HOU-MR amino acid 80 is the wild-type serine, while USA300-FPR3757 has a tyrosine that confers resistance [<xref ref-type="bibr" rid="B33">33</xref>]. Three non-synonymous SNPs occur within the IgG binding protein A. SNPs in intergenic regions could affect gene regulation: a four base deletion at 2,627,226 would place a SarA binding motif closer to the <italic>sarU </italic>promoter and could affect its transcription (Figure <xref ref-type="fig" rid="F7">7</xref>).</p><fig position="float" id="F7"><label>Figure 7</label><caption><p>DNA sequence of the <italic>sarU </italic>promoters in USA300-HOU-MR and FPR3757 showing -10 and -35 sequences (red) and SarA consensus binding sites (boxed).</p></caption><graphic xlink:href="1471-2180-7-99-7"/></fig><p>We compared the USA300 SNPs to all other sequenced <italic>S. aureus </italic>strains (Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>). For 39 of the SNPs, the other strains had the USA300-HOU-MR allele, while in 34 the allele was identical to FPR3757. For the remaining SNPs, the other strains showed both alleles, with some being triallelic.</p></sec><sec><title>Comparison of USA300-HOU-MR and of USA300-HOU-MS</title><p>We generated a draft sequence of the methicillin susceptible strain, USA300-HOU-MS, using the 454 Life Sciences pyrosequencing technology [<xref ref-type="bibr" rid="B34">34</xref>]. This strain is susceptible to all the antibiotics tested except penicillin (Table <xref ref-type="table" rid="T1">1</xref>). The sequences were assembled into 326 contigs with a total contig length of 2.8 Mb. We observed 32 SNPs between the HOU-MRSA and MSSA strains (Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>). We also identified two regions of DNA that are found in USA300-HOU-MR but not in USA300-HOU-MS. In contrast, we observed only one region in the MS strain not present in the USA300-HOU-MR strain. This 733 bp contig had a short DNA match (44 bp, 100% identity) to several staphylococcal sequences and a partial protein match (50% length, 38% identity) to a transport accessory protein. The sequences missing from USA300-HOU-MS included the SCC<italic>mec </italic>and ACME regions (34173&#x02013;88845, Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>). A second region not found in USA300-HOU-MS (680132 to 694219) includes a large number of staphylococcal conserved hypothetical proteins (Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>). Four of the proteins encoded by this region may be secreted (two non-classical). Also encoded are a possible lipoprotein, a peptidoglycan hydrolase, a cell division protein, ATP- and GTP-binding proteins, a replication protein, a possible secreted actin-binding protein, a possible ornithine carbamoyltransferase and a possible histidinol dehydrogenase.</p><p>We surveyed other sequenced staphylococcal genomes using TBLASTX for the presence of ORFs that were homologous to proteins encoded by the regions of USA300-HOU-MR that were missing in the MSSA strain. These are shown in Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>. With the exception of a few matches in the MW2 genome, the region from 51299 to 62735 seems to encode proteins unique to USA300-MR. This region also encodes four hypothetical and six conserved hypothetical proteins; several of these, although present, were not annotated in USA300-FPR3757. As previously discussed, this region may encode several secreted proteins. Though the arginine deiminase DNA region is unique to USA300 and to <italic>S. epidermidis </italic>ATCC 12228, genes encoding homologues of the proteins are found elsewhere in the USA300-HOU-MS genome and in most of the complete staphylococcal genomes. Proteins weakly similar (e value &#x0003e; e-10) to the nickel transporter were found in all staphylococcal genomes but this is likely due to generalized matches to other ABC transporter subunits. In contrast, the nickel transporter proteins are most homologous to proteins encoded by <italic>Staphylococcus haemolyticus</italic>. The proteins encoded by the region between 680132 and 694219 are also encoded by the genomes of two nosocomial MRSA strains, COL and MRSA252. These were not found in the CA isolate MW2.</p><p>USA300-HOU-MS does not carry plasmid pUSA300-HOU-MR but it does carry a 21 kb plasmid (pUSA300-HOU-MS) that encodes resistance to beta-lactams and to cadmium (Figure <xref ref-type="fig" rid="F6">6c</xref>). It also carries genes that are predicted to encode a bacteriocin and its associated immunity protein. The region from 9382 to 13575 on pUSA300-HOU-MS is nearly identical (95%) to nts 7644 to 11837 of plasmid pN315B. This corresponds to the region encoding the beta-lactamase gene and its regulators, BlaR and BlaI, and a Tn<italic>552 </italic>invertase and recombinase. In addition, this same region on pUSA300-HOU-MS is 96% identical to nts. 7615&#x02013;13573 on pUS300-HOU-MR. Thus, pUSA300-HOU-MS also appears to be mosaic. We also identified sequences homologous to pUSA01 on two contigs that were 1212 and 1278 bp in length, respectively. Since pUSA01 has now been sequenced twice, we did not attempt to complete the pUSA01 sequence in the MS strain.</p></sec><sec><title>Comparison with other completely sequenced staphylococcal genomes</title><p>We used Mauve [<xref ref-type="bibr" rid="B35">35</xref>] to align the sequences of the seventeen completed sequenced staphylococcal genomes (Figure <xref ref-type="fig" rid="F8">8</xref>) The alignment revealed that USA300 clusters with COL, NCTC8325, and Newman strains and that there are at least four clades of MRSA circulating. This clustering suggests that not all methicillin resistant S. aureus strains are intimately related further suggesting that different clones have given rise to groups of methicillin strains.</p><fig position="float" id="F8"><label>Figure 8</label><caption><p>Dendrogram of seventeen fully sequenced genomes generated by Mauve [35] and drawn using MEGA [58]. RP62A and ATCC12228 are <italic>S. epidermidis </italic>strains, JCSC1435 is an <italic>S. haemolyticus </italic>strain, and ATCC15305 is an <italic>S. saprophyticus </italic>strain. All others are <italic>S. aureus </italic>strains. The bar represents coalescent units.</p></caption><graphic xlink:href="1471-2180-7-99-8"/></fig></sec></sec><sec><title>Discussion</title><p>Because of the rapid and continuing increase of the prevalence of CA USA300 strains at TCH, we initiated the sequencing of two typical isolates from pediatric patients. During this time, Diep <italic>et al</italic>. [<xref ref-type="bibr" rid="B24">24</xref>] reported the sequence of USA300-FPR3757. USA300-HOU-MR revealed significant differences from USA300-FPR3757. Though USA300-FPR3757 was chosen as a highly resistant isolate, USA300-HOU-MR, a purely community-acquired strain, harbours a large plasmid encoding multiple antibiotic and cadmium resistance. The mosaic composition of plasmid pUSA300-HOU-MR representing three different staphylococcal plasmids points toward significant genetic exchange between staphylococcal isolates and species. Among the numerous antibacterial resistance genes found on the plasmid, the conferred resistance to bacitracin, a common constituent of topical over-the-counter ointments used to treat or prevent cutaneous infections, is most intriguing. In contrast to other MR strains, the cadmium resistance genes were found on a plasmid and not on the chromosome. Genome-wide alignments revealed that not all MRSA are tightly clustered.</p><p>Several indels between USA300-HOU-MR and USA300-FPR3757 were identified. The majority of the indels were within repeat regions or rRNAs, though a 13 kb segment was located in different regions of the two genomes. In USA300-FPR3757, the region is inserted between two genes. In USA300-HOU-MR, the segment interrupts an operon (<italic>snoABCDEFG</italic>) that has been implicated in susceptibility to thrombin-induced platelet microbicidal protein 1 (tPMP-1). Bayer <italic>et al</italic>. [<xref ref-type="bibr" rid="B31">31</xref>] have shown that interruption of this operon reduces the susceptibility of <italic>S. aureus </italic>to tPMP-1 <italic>in vitro</italic>. Resistance to tPMP-1 may allow US300-HOU-MR to cause more serious disease by evasion of platelet-mediated killing in the blood stream. USA300-FPR3757 has an additional repeat within the gene encoding the IgG binding protein A, so it is possible that IgG binding protein is subject to structural variation. We also identified nine SNPs within this gene. This may suggest that the IgG binding protein undergoes significant variation, possibly in response to the host.</p><p>Two prophage were identified, one carrying the PVL genes and the other an hemolysin converting phage carrying the staphylokinase, chemotaxis inhibitory protein and staphylococcal complement inhibitor genes. USA300 lacks a copy of prophage L54a. The GehD lipase, whose gene contains the prophage attachment site, is likely to play a role in colonization events. [<xref ref-type="bibr" rid="B36">36</xref>].</p><p>SNP analysis revealed 47 non-synonymous, non-conserved differences between the strains. Some of these may affect protein function. Two of these, one in <italic>gyrA </italic>and one in <italic>parC</italic>, are consistent with antibiotic susceptibilities reported in Table <xref ref-type="table" rid="T3">3</xref>. The SNP analysis also revealed a number of sequencing errors in the FPR3757 sequence.</p><p>To further our understanding of the evolution of the USA300-HOU-MR strain, we created a draft sequence of an MS isolate from TCH. This revealed two regions of the MR strain not found in the MS strain. It is likely that the progenitor MS strain acquired these regions (along with the SCC<italic>mec</italic>IVa and the arginine deiminase region) by recombination to become USA300-HOU-MR. We propose that USA300-HOU-MS first acquired the arginine deiminase region plus the cassette chromosome recombinase genes (<italic>ccrA</italic>B) from a strain similar to <italic>S. epidermidis </italic>ATCC12228. This is based on the observation that the <italic>ccrAB </italic>genes in USA300-HOU-MR are 95&#x02013;100% identical to those found near the arginine deiminase region in <italic>S. epidermidis </italic>ATCC12228. The SCC<italic>mec </italic>was likely acquired in a separate event from another MRSA, or from a MR-<italic>S. epidermidis strain</italic>, via <italic>ccrAB </italic>recombination within the repeats flanking the arginine deiminase region [<xref ref-type="bibr" rid="B24">24</xref>]. US300-HOU-MS lacks a probable nickel ABC transporter that is linked to ACME in USA300-MR. It is possible that increased intracellular stores of nickel in USA300-HOU-MR could contribute to virulence by enhancing the activity of the nickel-dependent urease. [<xref ref-type="bibr" rid="B37">37</xref>]. The MS strain also lacks a copy of the P-ATPase copper transporter gene; such transporters have been shown to be involved in virulence in <italic>Listeria monocytogenes </italic>[<xref ref-type="bibr" rid="B38">38</xref>]. Another potential virulence factor revealed by comparison of the MR and MS strains is a possible secreted actin binding protein.</p><p>We used a relatively new predictive tool, SecretomeP2.0, to identify non-classically secreted proteins [<xref ref-type="bibr" rid="B39">39</xref>] since it is not possible to predict the function of most of these proteins by BLAST analysis. We found 406 high scoring genes predicted to encode non-classically secreted proteins in USA300-HOU-MR (Additional file <xref ref-type="supplementary-material" rid="S3">3</xref>). If some of these are indeed secreted then they may be candidate virulence factors for future study.</p></sec><sec><title>Conclusion</title><p>Comparative analyses have revealed that USA300-MRSA is highly similar to some MRSA strains suggesting that the differences in pathogenesis are due to subtle changes rather than to large-scale acquisition of virulence factor genes. Significantly, however, is the difference in plasmid content and antibiotic susceptibility profiles between the two USA300 isolates. The presence of a large multidrug resistance plasmid in a community-acquired isolate is unexpected. The combination of Sanger sequencing and 454 data allowed us to economically derive the complete sequence of USA300-HOU-MR and MS. Future sequencing of additional USA300 isolates will further characterize the genotypic variation in this clone. With exception of the antibiotic susceptibility profiles, the phenotypic results of the genotypic variation have yet to be discovered.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>USA300 isolates</title><p>Clinical isolate TCH1516 (USA300-HOU-MR) was obtained from an adolescent patient with severe sepsis syndrome [<xref ref-type="bibr" rid="B15">15</xref>]. The strain was representative of the predominant <italic>Sma </italic>I pulsed field gel electrophoresis (PFGE) pattern (Figure <xref ref-type="fig" rid="F2">2</xref>) observed in our clonal studies on CA-MRSA at TCH [<xref ref-type="bibr" rid="B9">9</xref>] and is indistinguishable from the CDC type strain USA300.0114 obtained from the Network on Antimicrobial Resistance in <italic>Staphylococcus aureus </italic>[<xref ref-type="bibr" rid="B40">40</xref>]. The strain is sequence type 8 (ST8). Clinical isolate TCH959 (USA300-HOU-MS) was obtained from a 12 year old white female with a buttock abscess. The PFGE profile of the MSSA strain differed from USA300.0114 by two fragments. USA300-HOU-MS lacked a fragment of ca. 230 kb, which is present in the USA300-HOU-MR and the MS pattern included a 180 kb fragment absent in MR. Additionally, the <italic>ca</italic>. 300 kb fragment was slightly larger in the MS strain. FPR3757 was kindly provided by Francois Perdreau-Remington (University of California, San Francisco).</p></sec><sec><title>Antimicrobial susceptibilities</title><p>Antimicrobial susceptibilities were obtained by microbroth dilution assays using Clinical Laboratory Standards Institute (CLSI) guidelines [<xref ref-type="bibr" rid="B41">41</xref>] (Table <xref ref-type="table" rid="T3">3</xref>). Unlike the other sequenced USA300 isolate [<xref ref-type="bibr" rid="B24">24</xref>], USA300-HOU is susceptible to clindamycin, tetracycline, ciprofloxacin and mupirocin.</p></sec><sec><title>DNA sequencing and genome assembly</title><p>Genomic DNA was purified from CsCl gradients [<xref ref-type="bibr" rid="B42">42</xref>] and DNA sequencing was performed by Sanger dideoxy whole genome shotgun (WGS) and by the 454 Life Sciences pyrosequencing strategies [<xref ref-type="bibr" rid="B34">34</xref>]. Genomic and plasmid DNA from USA300-HOU-MR was sheared to a size of 2 kb by nebulization, and cloned into a derivative of pUC18 [<xref ref-type="bibr" rid="B43">43</xref>]. The clones were used for WGS DNA sequencing to 8&#x000d7; coverage by using dye terminator chemistry, data were collected on ABI 3730 sequencers, and reads were assembled using the ATLAS assembler [<xref ref-type="bibr" rid="B44">44</xref>]. This sequence was supplemented with contigs assembled from shorter reads generated on a 454 Life Sciences GS20 sequencer to 15&#x000d7; coverage. This combined assembly was refined by sequencing PCR products to fill in gaps and to resolve ambiguous regions. DNA from USA300-HOU-MS was sequenced by the 454 method to 17&#x000d7; coverage and the sequences assembled using the 454 Newbler assembler. The complete sequences have been deposited at DDBJ/EMBL/GenBank under the following the accession numbers: CP000730 (USA300-HOU-MR); CP000731 (pUSA300-HOU-MR); CP000732 (pUSA300-HOU-MS). The USA300-HOU-MS has been deposited under the project accession AASB00000000. The version described in this manuscript is the first version, AASB01000000.</p><p>Glimmer [<xref ref-type="bibr" rid="B45">45</xref>] and GeneMark [<xref ref-type="bibr" rid="B46">46</xref>] were used independently to predict open reading frames (ORFs). Predicted proteins were compared to the nr database using BLASTP. Visualization of gene predictions was performed using the Genboree system [<xref ref-type="bibr" rid="B47">47</xref>] and the CONAN database [<xref ref-type="bibr" rid="B48">48</xref>]. Two individuals independently annotated each ORF and annotations were reconciled and converted to single entries within the database. Proteins lacking a homolog in the nr database were called hypothetical proteins, those with a homolog of no known function were called conserved hypothetical proteins and of these, if homologs were only in other staphylococci they were called staphylococcal conserved hypothetical proteins.</p></sec><sec><title>Sequence analysis</title><p>DNA comparisons were performed with BLASTN and BLASTZ. Protein sequences were analyzed by BLASTP and BLASTX and by the use of the predictive tools InterProScan [<xref ref-type="bibr" rid="B49">49</xref>], PFP [<xref ref-type="bibr" rid="B50">50</xref>], PSORTb [<xref ref-type="bibr" rid="B51">51</xref>], Helix-Turn-Helix Predictor [<xref ref-type="bibr" rid="B52">52</xref>], MEROPs [<xref ref-type="bibr" rid="B53">53</xref>], and the Tcdb Transport Classification database [<xref ref-type="bibr" rid="B54">54</xref>]. Non-classically secreted proteins (those lacking signal peptides) were predicted using SecretomeP2.0 [<xref ref-type="bibr" rid="B39">39</xref>]. Riboswitches and non-coding small RNAs were identified using BLASTN, the Riboswitch finder [<xref ref-type="bibr" rid="B55">55</xref>] and Riboswitch Explorer [<xref ref-type="bibr" rid="B56">56</xref>]. ClustalW [<xref ref-type="bibr" rid="B57">57</xref>] and Mauve [<xref ref-type="bibr" rid="B35">35</xref>] were used for multiple sequence alignments and PHLYIP bootstrapping and tree generation (evolution.genetics.washington.edu/phylip.html). Single nucleotide polymorphisms (SNPs) between USA300-MRSA-HOU and FPR3757 were verified by resequencing.</p></sec></sec><sec><title>Authors' contributions</title><p>SKH performed much of the post-annotation analysis and wrote the draft of the manuscript. SKH, KGH, EOM, RMF, YL, OI, SY, JP, MT, AU, GEF annotated the genome. XQ and HJ contributed bioinformatics support. YS, TMW and AMC performed the SNP verification. DMM, LH, YD, SD, PRB, CJB, HHD, ACH, MH, CLK, SLL, WL, LVN, QW and JZ composed the sequencing and finishing team. KGH, RMF, EOM, SLK and GMW assisted critical review of the manuscript. All authors read and approved the final manuscript.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p>DNA regions present in USA300-HOU-MR but missing in USA300-HOU-MS and their presence in other sequenced staphylococcal genomes.</p></caption><media xlink:href="1471-2180-7-99-S1.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p>Single nucleotide polymorphisms and short insertions/deletions between USA300-MR, USA300-MS and FPR3757. Alleles in other sequenced <italic>S. aureus </italic>strains are also listed.</p></caption><media xlink:href="1471-2180-7-99-S2.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S3"><caption><title>Additional file 3</title><p>Predicted non-classically secreted proteins.</p></caption><media xlink:href="1471-2180-7-99-S3.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank Prisma Energy International and Vivian L. Smith Foundation for funding this project. We also would like to thank Magnus Hook, Gabriella Bowden, Berenice Carrillo, and Petra Matejkova for assistance during the early phases of the project.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deresinski</surname><given-names>S</given-names></name></person-group><article-title>Methicillin-resistant <italic>Staphylococcus aureus</italic>: an evolutionary, epidemiologic, and therapeutic odyssey</article-title><source>Clin Infect Dis</source><year>2005</year><volume>40</volume><fpage>562</fpage><lpage>573</lpage><pub-id pub-id-type="pmid">15712079</pub-id><pub-id pub-id-type="doi">10.1086/427701</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Appelbaum</surname><given-names>PC</given-names></name></person-group><article-title>MRSA &#x02013; the tip of the iceberg</article-title><source>Clin Microbiol Infect</source><year>2006</year><volume>12</volume><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">16524422</pub-id><pub-id pub-id-type="doi">10.1111/j.1469-0691.2006.01402.x</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coombs</surname><given-names>GW</given-names></name><name><surname>Nimmo</surname><given-names>GR</given-names></name><name><surname>Bell</surname><given-names>JM</given-names></name><name><surname>Huygens</surname><given-names>F</given-names></name><name><surname>O'Brien</surname><given-names>FG</given-names></name><name><surname>Malkowski</surname><given-names>MJ</given-names></name><name><surname>Pearson</surname><given-names>JC</given-names></name><name><surname>Stephens</surname><given-names>AJ</given-names></name><name><surname>Giffard</surname><given-names>PM</given-names></name></person-group><article-title>Genetic diversity amongcommunity methicillin-resistant <italic>Staphylococcus aureus </italic>strains causing outpatient infections in Australia</article-title><source>J Clin Microbiol</source><year>2004</year><volume>42</volume><fpage>4735</fpage><lpage>4743</lpage><pub-id pub-id-type="pmid">15472334</pub-id><pub-id pub-id-type="doi">10.1128/JCM.42.10.4735-4743.2004</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CJ</given-names></name><name><surname>Huang</surname><given-names>YC</given-names></name></person-group><article-title>Community-acquired methicillin-resistant <italic>Staphylococcus aureus </italic>in Taiwan</article-title><source>J Microbiol Immunol Infect</source><year>2005</year><volume>38</volume><fpage>376</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">16341337</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanssen</surname><given-names>AM</given-names></name><name><surname>Fossum</surname><given-names>A</given-names></name><name><surname>Mikalsen</surname><given-names>J</given-names></name><name><surname>Halvorsen</surname><given-names>DS</given-names></name><name><surname>Bukholm</surname><given-names>G</given-names></name><name><surname>Sollid</surname><given-names>JU</given-names></name></person-group><article-title>Dissemination of community-acquired methicillin-resistant <italic>Staphylococcus aureus </italic>clones in northern Norway: sequence types 8 and 80 predominate</article-title><source>J Clin Microbiol</source><year>2005</year><volume>43</volume><fpage>2118</fpage><lpage>2124</lpage><pub-id pub-id-type="pmid">15872230</pub-id><pub-id pub-id-type="doi">10.1128/JCM.43.5.2118-2124.2005</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>XX</given-names></name><name><surname>Galiana</surname><given-names>A</given-names></name><name><surname>Pedreira</surname><given-names>W</given-names></name><name><surname>Mowszowicz</surname><given-names>M</given-names></name><name><surname>Christophersen</surname><given-names>I</given-names></name><name><surname>Machiavello</surname><given-names>S</given-names></name><name><surname>Lope</surname><given-names>L</given-names></name><name><surname>Benaderet</surname><given-names>S</given-names></name><name><surname>Buela</surname><given-names>F</given-names></name><name><surname>Vincentino</surname><given-names>W</given-names></name><name><surname>Albini</surname><given-names>M</given-names></name><name><surname>Bertaux</surname><given-names>O</given-names></name><name><surname>Constenla</surname><given-names>I</given-names></name><name><surname>Bagnulo</surname><given-names>H</given-names></name><name><surname>Llosa</surname><given-names>L</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Hiramatsu</surname><given-names>K</given-names></name></person-group><article-title>Community-acquired methicillin-resistant <italic>Staphylococcus aureus</italic>, Uruguay</article-title><source>Emerg Infect Dis</source><year>2005</year><volume>11</volume><fpage>973</fpage><lpage>976</lpage><pub-id pub-id-type="pmid">15963301</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McDougal</surname><given-names>LK</given-names></name><name><surname>Steward</surname><given-names>CD</given-names></name><name><surname>Killgore</surname><given-names>GE</given-names></name><name><surname>Chaitram</surname><given-names>JM</given-names></name><name><surname>McAllister</surname><given-names>SK</given-names></name><name><surname>Tenover</surname><given-names>FC</given-names></name></person-group><article-title>Pulsed-field gel electrophoresis typing of oxacillin-resistant <italic>Staphylococcus aureus </italic>isolates from the United States: establishing a national database</article-title><source>J Clin Microbiol</source><year>2003</year><volume>41</volume><fpage>5113</fpage><lpage>5120</lpage><pub-id pub-id-type="pmid">14605147</pub-id><pub-id pub-id-type="doi">10.1128/JCM.41.11.5113-5120.2003</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>ES</given-names></name><name><surname>Diep</surname><given-names>BA</given-names></name><name><surname>Carleton</surname><given-names>HA</given-names></name><name><surname>Charlebois</surname><given-names>ED</given-names></name><name><surname>Sensabaugh</surname><given-names>GF</given-names></name><name><surname>Haller</surname><given-names>BL</given-names></name><name><surname>Perdreau-Remington</surname><given-names>F</given-names></name></person-group><article-title>Increasing prevalence of methicillin-resistant <italic>Staphylococcus aureus </italic>infection in California jails</article-title><source>Clin Infect Dis</source><year>2003</year><volume>37</volume><fpage>1384</fpage><lpage>1388</lpage><pub-id pub-id-type="pmid">14583874</pub-id><pub-id pub-id-type="doi">10.1086/379019</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mishaan</surname><given-names>AM</given-names></name><name><surname>Mason</surname><given-names>EO</given-names><suffix>Jr</suffix></name><name><surname>Martinez-Aguilar</surname><given-names>G</given-names></name><name><surname>Hammerman</surname><given-names>W</given-names></name><name><surname>Propst</surname><given-names>JJ</given-names></name><name><surname>Stankiewicz</surname><given-names>P</given-names></name><name><surname>Kaplan</surname><given-names>SL</given-names></name><name><surname>Hulten</surname><given-names>K</given-names></name></person-group><article-title>Emergence of a predominant clone of community-acquired <italic>Staphylococcus aureus </italic>among children in Houston, Texas</article-title><source>Pediatr Infect Dis J</source><year>2005</year><volume>24</volume><fpage>201</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">15750454</pub-id><pub-id pub-id-type="doi">10.1097/01.inf.0000151107.29132.70</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dietrich</surname><given-names>DW</given-names></name><name><surname>Auld</surname><given-names>DB</given-names></name><name><surname>Mermel</surname><given-names>LA</given-names></name></person-group><article-title>Community-acquiredmethicillin-resistant <italic>Staphylococcus aureus </italic>in southern New England children</article-title><source>Pediatrics</source><year>2004</year><volume>113</volume><fpage>e347</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">15060266</pub-id><pub-id pub-id-type="doi">10.1542/peds.113.4.e347</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kazakova</surname><given-names>SV</given-names></name><name><surname>Hageman</surname><given-names>JC</given-names></name><name><surname>Matava</surname><given-names>M</given-names></name><name><surname>Srinivasan</surname><given-names>A</given-names></name><name><surname>Phelan</surname><given-names>L</given-names></name><name><surname>Garfinkel</surname><given-names>B</given-names></name><name><surname>Boo</surname><given-names>T</given-names></name><name><surname>McAllister</surname><given-names>S</given-names></name><name><surname>Anderson</surname><given-names>J</given-names></name><name><surname>Jensen</surname><given-names>B</given-names></name><name><surname>Dodson</surname><given-names>D</given-names></name><name><surname>Lonsway</surname><given-names>D</given-names></name><name><surname>McDougal</surname><given-names>LK</given-names></name><name><surname>Arduino</surname><given-names>M</given-names></name><name><surname>Fraser</surname><given-names>VJ</given-names></name><name><surname>Killgore</surname><given-names>G</given-names></name><name><surname>Tenover</surname><given-names>FC</given-names></name><name><surname>Cody</surname><given-names>S</given-names></name><name><surname>Jernigan</surname><given-names>DB</given-names></name></person-group><article-title>A clone of methicillin-resistant <italic>Staphylococcus aureus </italic>among professional football players</article-title><source>N Engl J Med</source><year>2005</year><volume>352</volume><fpage>468</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">15689585</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa042859</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moran</surname><given-names>GJ</given-names></name><name><surname>Krishnadasan</surname><given-names>A</given-names></name><name><surname>Gorwitz</surname><given-names>RJ</given-names></name><name><surname>Fosheim</surname><given-names>GE</given-names></name><name><surname>McDougal</surname><given-names>LK</given-names></name><name><surname>Carey</surname><given-names>RB</given-names></name><name><surname>Talan</surname><given-names>DA</given-names></name></person-group><article-title>Methicillin-resistant <italic>S. aureus </italic>infections among patients in the emergency department</article-title><source>N Engl J Med</source><year>2006</year><volume>355</volume><fpage>666</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">16914702</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa055356</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>SL</given-names></name><name><surname>Hulten</surname><given-names>KG</given-names></name><name><surname>Gonzalez</surname><given-names>BE</given-names></name><name><surname>Hammerman</surname><given-names>WA</given-names></name><name><surname>Lamberth</surname><given-names>L</given-names></name><name><surname>Versalovic</surname><given-names>J</given-names></name><name><surname>Mason</surname><given-names>EO</given-names><suffix>Jr</suffix></name></person-group><article-title>Three-year surveillance of community-acquired <italic>Staphylococcus aureus </italic>infections in children</article-title><source>Clin Infect Dis</source><year>2005</year><volume>40</volume><fpage>1785</fpage><lpage>1791</lpage><pub-id pub-id-type="pmid">15909267</pub-id><pub-id pub-id-type="doi">10.1086/430312</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>BE</given-names></name><name><surname>Hulten</surname><given-names>KG</given-names></name><name><surname>Dishop</surname><given-names>MK</given-names></name><name><surname>Lamberth</surname><given-names>LB</given-names></name><name><surname>Hammerman</surname><given-names>WA</given-names></name><name><surname>Mason</surname><given-names>EO</given-names><suffix>Jr</suffix></name><name><surname>Kaplan</surname><given-names>SL</given-names></name></person-group><article-title>Pulmonary manifestations in childrenwith invasive community-acquired <italic>Staphylococcus aureus </italic>infection</article-title><source>Clin Infect Dis</source><year>2005</year><volume>41</volume><fpage>583</fpage><lpage>590</lpage><pub-id pub-id-type="pmid">16080077</pub-id><pub-id pub-id-type="doi">10.1086/432475</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>BE</given-names></name><name><surname>Martinez-Aguilar</surname><given-names>G</given-names></name><name><surname>Hulten</surname><given-names>KG</given-names></name><name><surname>Hammerman</surname><given-names>WA</given-names></name><name><surname>Coss-Bu</surname><given-names>J</given-names></name><name><surname>Avalos-Mishaan</surname><given-names>A</given-names></name><name><surname>Mason</surname><given-names>EO</given-names><suffix>Jr</suffix></name><name><surname>Kaplan</surname><given-names>SL</given-names></name></person-group><article-title>Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>Pediatrics</source><year>2005</year><volume>115</volume><fpage>642</fpage><lpage>648</lpage><pub-id pub-id-type="pmid">15741366</pub-id><pub-id pub-id-type="doi">10.1542/peds.2004-2300</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>SL</given-names></name></person-group><article-title>Treatment of community-associated methicillin-resistant <italic>Staphylococcus aureus </italic>infections</article-title><source>Pediatr Infect Dis J</source><year>2005</year><volume>24</volume><fpage>457</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15876948</pub-id><pub-id pub-id-type="doi">10.1097/01.inf.0000164162.00163.9d</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bocchini</surname><given-names>CE</given-names></name><name><surname>Hulten</surname><given-names>KG</given-names></name><name><surname>Mason</surname><given-names>EO</given-names><suffix>Jr</suffix></name><name><surname>Gonzalez</surname><given-names>BE</given-names></name><name><surname>Hammerman</surname><given-names>WA</given-names></name><name><surname>Kaplan</surname><given-names>SL</given-names></name></person-group><article-title>Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous <italic>Staphylococcus aureus </italic>osteomyelitis in children</article-title><source>Pediatrics</source><year>2006</year><volume>117</volume><fpage>433</fpage><lpage>440</lpage><pub-id pub-id-type="pmid">16452363</pub-id><pub-id pub-id-type="doi">10.1542/peds.2005-0566</pub-id></citation></ref><ref id="B18"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>BE</given-names></name><name><surname>Hulten</surname><given-names>KG</given-names></name><name><surname>Teruya</surname><given-names>J</given-names></name><name><surname>Hammerman</surname><given-names>W</given-names></name><name><surname>Mason</surname><given-names>EO</given-names><suffix>Jr</suffix></name><name><surname>Kaplan</surname><given-names>SL</given-names></name></person-group><article-title>Deep venous thrombophlebitis in patients with <italic>Staphylococcus aureus </italic>infections</article-title><source>Society for Pediatric Res: 2005</source><year>2005</year></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>LG</given-names></name><name><surname>Perdreau-Remington</surname><given-names>F</given-names></name><name><surname>Rieg</surname><given-names>G</given-names></name><name><surname>Mehdi</surname><given-names>S</given-names></name><name><surname>Perlroth</surname><given-names>J</given-names></name><name><surname>Bayer</surname><given-names>AS</given-names></name><name><surname>Tang</surname><given-names>AW</given-names></name><name><surname>Phung</surname><given-names>TO</given-names></name><name><surname>Spellberg</surname><given-names>B</given-names></name></person-group><article-title>Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles</article-title><source>N Engl J Med</source><year>2005</year><volume>352</volume><fpage>1445</fpage><lpage>1453</lpage><pub-id pub-id-type="pmid">15814880</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa042683</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>JS</given-names></name><name><surname>Doherty</surname><given-names>MC</given-names></name><name><surname>Lopatin</surname><given-names>U</given-names></name><name><surname>Johnston</surname><given-names>CP</given-names></name><name><surname>Sinha</surname><given-names>G</given-names></name><name><surname>Ross</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>M</given-names></name><name><surname>Hansel</surname><given-names>NN</given-names></name><name><surname>Perl</surname><given-names>T</given-names></name><name><surname>Ticehurst</surname><given-names>JR</given-names></name><name><surname>Carroll</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>DL</given-names></name><name><surname>Nuermberger</surname><given-names>E</given-names></name><name><surname>Bartlett</surname><given-names>JG</given-names></name></person-group><article-title>Severe community-onset pneumonia in healthy adults caused by methicillin-resistant <italic>Staphylococcus aureus </italic>carrying the Panton-Valentine leukocidin genes</article-title><source>Clin Infect Dis</source><year>2005</year><volume>40</volume><fpage>100</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">15614698</pub-id><pub-id pub-id-type="doi">10.1086/427148</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>BE</given-names></name><name><surname>Teruya</surname><given-names>J</given-names></name><name><surname>Mahoney</surname><given-names>DH</given-names><suffix>Jr</suffix></name><name><surname>Hulten</surname><given-names>KG</given-names></name><name><surname>Edwards</surname><given-names>R</given-names></name><name><surname>Lamberth</surname><given-names>LB</given-names></name><name><surname>Hammerman</surname><given-names>WA</given-names></name><name><surname>Mason</surname><given-names>EO</given-names><suffix>Jr</suffix></name><name><surname>Kaplan</surname><given-names>SL</given-names></name></person-group><article-title>Venous thrombosis associated with staphylococcal osteomyelitis in children</article-title><source>Pediatrics</source><year>2006</year><volume>117</volume><fpage>1673</fpage><lpage>1679</lpage><pub-id pub-id-type="pmid">16651323</pub-id><pub-id pub-id-type="doi">10.1542/peds.2005-2009</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Enright</surname><given-names>MC</given-names></name><name><surname>Day</surname><given-names>NP</given-names></name><name><surname>Davies</surname><given-names>CE</given-names></name><name><surname>Peacock</surname><given-names>SJ</given-names></name><name><surname>Spratt</surname><given-names>BG</given-names></name></person-group><article-title>Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of <italic>Staphylococcus aureus</italic></article-title><source>J Clin Microbiol</source><year>2000</year><volume>38</volume><fpage>1008</fpage><lpage>1015</lpage><pub-id pub-id-type="pmid">10698988</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>DA</given-names></name><name><surname>Enright</surname><given-names>MC</given-names></name></person-group><article-title>Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus</article-title><source>Antimicrob Agents Chemother</source><year>2003</year><volume>47</volume><fpage>3926</fpage><lpage>3934</lpage><pub-id pub-id-type="pmid">14638503</pub-id><pub-id pub-id-type="doi">10.1128/AAC.47.12.3926-3934.2003</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diep</surname><given-names>BA</given-names></name><name><surname>Gill</surname><given-names>SR</given-names></name><name><surname>Chang</surname><given-names>RF</given-names></name><name><surname>Phan</surname><given-names>TH</given-names></name><name><surname>Chen</surname><given-names>JH</given-names></name><name><surname>Davidson</surname><given-names>MG</given-names></name><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Carleton</surname><given-names>HA</given-names></name><name><surname>Mongodin</surname><given-names>EF</given-names></name><name><surname>Sensabaugh</surname><given-names>GF</given-names></name><name><surname>Perdreau-Remington</surname><given-names>F</given-names></name></person-group><article-title>Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>Lancet</source><year>2006</year><volume>367</volume><fpage>731</fpage><lpage>739</lpage><pub-id pub-id-type="pmid">16517273</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(06)68231-7</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>SR</given-names></name><name><surname>Fouts</surname><given-names>DE</given-names></name><name><surname>Archer</surname><given-names>GL</given-names></name><name><surname>Mongodin</surname><given-names>EF</given-names></name><name><surname>Deboy</surname><given-names>RT</given-names></name><name><surname>Ravel</surname><given-names>J</given-names></name><name><surname>Paulsen</surname><given-names>IT</given-names></name><name><surname>Kolonay</surname><given-names>JF</given-names></name><name><surname>Brinkac</surname><given-names>L</given-names></name><name><surname>Beanan</surname><given-names>M</given-names></name><name><surname>Dodson</surname><given-names>RJ</given-names></name><name><surname>Daugherty</surname><given-names>SC</given-names></name><name><surname>Madupu</surname><given-names>R</given-names></name><name><surname>Angiuoli</surname><given-names>SV</given-names></name><name><surname>Durkin</surname><given-names>AS</given-names></name><name><surname>Haft</surname><given-names>DH</given-names></name><name><surname>Vamathevan</surname><given-names>J</given-names></name><name><surname>Khouri</surname><given-names>H</given-names></name><name><surname>Utterback</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Dimitrov</surname><given-names>G</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Qin</surname><given-names>H</given-names></name><name><surname>Weidman</surname><given-names>J</given-names></name><name><surname>Tran</surname><given-names>K</given-names></name><name><surname>Kang</surname><given-names>K</given-names></name><name><surname>Hance</surname><given-names>IR</given-names></name><name><surname>Nelson</surname><given-names>KE</given-names></name><name><surname>Fraser</surname><given-names>CM</given-names></name></person-group><article-title>Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant <italic>Staphylococcus aureus </italic>strain and a biofilm-producing methicillin-resistant <italic>Staphylococcus epidermidis </italic>strain</article-title><source>J Bacteriol</source><year>2005</year><volume>187</volume><fpage>2426</fpage><lpage>2438</lpage><pub-id pub-id-type="pmid">15774886</pub-id><pub-id pub-id-type="doi">10.1128/JB.187.7.2426-2438.2005</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Novick</surname><given-names>RP</given-names></name><name><surname>Subedi</surname><given-names>A</given-names></name></person-group><article-title>The SaPIs: mobile pathogenicity islands of <italic>Staphylococcus</italic></article-title><source>Chem Immunol Allergy</source><year>2007</year><volume>93</volume><fpage>42</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">17369699</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindsay</surname><given-names>JA</given-names></name><name><surname>Holden</surname><given-names>MT</given-names></name></person-group><article-title><italic>Staphylococcus aureus</italic>: superbug, super genome?</article-title><source>Trends Microbiol</source><year>2004</year><volume>12</volume><fpage>378</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">15276614</pub-id><pub-id pub-id-type="doi">10.1016/j.tim.2004.06.004</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narita</surname><given-names>S</given-names></name><name><surname>Kaneko</surname><given-names>J</given-names></name><name><surname>Chiba</surname><given-names>J</given-names></name><name><surname>Piemont</surname><given-names>Y</given-names></name><name><surname>Jarraud</surname><given-names>S</given-names></name><name><surname>Etienne</surname><given-names>J</given-names></name><name><surname>Kamio</surname><given-names>Y</given-names></name></person-group><article-title>Phage conversion of Panton-Valentine leukocidin in <italic>Staphylococcus aureus</italic>: molecular analysis of a PVL-converting phage, phiSLT</article-title><source>Gene</source><year>2001</year><volume>268</volume><fpage>195</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">11368915</pub-id><pub-id pub-id-type="doi">10.1016/S0378-1119(01)00390-0</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaneko</surname><given-names>J</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Narita</surname><given-names>S</given-names></name><name><surname>Tomita</surname><given-names>T</given-names></name><name><surname>Kamio</surname><given-names>Y</given-names></name></person-group><article-title>Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage phiPVL carrying Panton-Valentine leukocidin genes</article-title><source>Gene</source><year>1998</year><volume>215</volume><fpage>57</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">9666077</pub-id><pub-id pub-id-type="doi">10.1016/S0378-1119(98)00278-9</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Wamel</surname><given-names>WJ</given-names></name><name><surname>Rooijakkers</surname><given-names>SH</given-names></name><name><surname>Ruyken</surname><given-names>M</given-names></name><name><surname>van Kessel</surname><given-names>KP</given-names></name><name><surname>van Strijp</surname><given-names>JA</given-names></name></person-group><article-title>The innate immune modulators staphylococcal complementinhibitor and chemotaxis inhibitory protein of <italic>Staphylococcus aureus </italic>are located on beta-hemolysin-converting bacteriophages</article-title><source>J Bacteriol</source><year>2006</year><volume>188</volume><fpage>1310</fpage><lpage>1315</lpage><pub-id pub-id-type="pmid">16452413</pub-id><pub-id pub-id-type="doi">10.1128/JB.188.4.1310-1315.2006</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bayer</surname><given-names>AS</given-names></name><name><surname>McNamara</surname><given-names>P</given-names></name><name><surname>Yeaman</surname><given-names>MR</given-names></name><name><surname>Lucindo</surname><given-names>N</given-names></name><name><surname>Jones</surname><given-names>T</given-names></name><name><surname>Cheung</surname><given-names>AL</given-names></name><name><surname>Sahl</surname><given-names>HG</given-names></name><name><surname>Proctor</surname><given-names>RA</given-names></name></person-group><article-title>Transposon disruption of the complex I NADH oxidoreductase gene (<italic>snoD</italic>) in <italic>Staphylococcus aureus </italic>is associated with reduced susceptibility to the microbicidal activity of thrombin-induced platelet microbicidal protein 1</article-title><source>J Bacteriol</source><year>2006</year><volume>188</volume><fpage>211</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">16352837</pub-id><pub-id pub-id-type="doi">10.1128/JB.188.1.211-222.2006</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sreedharan</surname><given-names>S</given-names></name><name><surname>Oram</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>B</given-names></name><name><surname>Peterson</surname><given-names>LR</given-names></name><name><surname>Fisher</surname><given-names>LM</given-names></name></person-group><article-title>DNA gyrase <italic>gyrA </italic>mutations in ciprofloxacin-resistant strains of <italic>Staphylococcus aureus</italic>: close similarity with quinolone resistance mutations in <italic>Escherichia coli</italic></article-title><source>J Bacteriol</source><year>1990</year><volume>172</volume><fpage>7260</fpage><lpage>7262</lpage><pub-id pub-id-type="pmid">2174869</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferrero</surname><given-names>L</given-names></name><name><surname>Cameron</surname><given-names>B</given-names></name><name><surname>Crouzet</surname><given-names>J</given-names></name></person-group><article-title>Analysis of <italic>gyrA </italic>and <italic>grlA </italic>mutations in stepwise-selected ciprofloxacin-resistant mutants of <italic>Staphylococcus aureus</italic></article-title><source>Antimicrob Agents Chemother</source><year>1995</year><volume>39</volume><fpage>1554</fpage><lpage>1558</lpage><pub-id pub-id-type="pmid">7492103</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Margulies</surname><given-names>M</given-names></name><name><surname>Egholm</surname><given-names>M</given-names></name><name><surname>Altman</surname><given-names>WE</given-names></name><name><surname>Attiya</surname><given-names>S</given-names></name><name><surname>Bader</surname><given-names>JS</given-names></name><name><surname>Bemben</surname><given-names>LA</given-names></name><name><surname>Berka</surname><given-names>J</given-names></name><name><surname>Braverman</surname><given-names>MS</given-names></name><name><surname>Chen</surname><given-names>YJ</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Dewell</surname><given-names>SB</given-names></name><name><surname>Du</surname><given-names>L</given-names></name><name><surname>Fierro</surname><given-names>JM</given-names></name><name><surname>Gomes</surname><given-names>XV</given-names></name><name><surname>Godwin</surname><given-names>BC</given-names></name><name><surname>He</surname><given-names>W</given-names></name><name><surname>Helgesen</surname><given-names>S</given-names></name><name><surname>Ho</surname><given-names>CH</given-names></name><name><surname>Irzyk</surname><given-names>GP</given-names></name><name><surname>Jando</surname><given-names>SC</given-names></name><name><surname>Alenquer</surname><given-names>ML</given-names></name><name><surname>Jarvie</surname><given-names>TP</given-names></name><name><surname>Jirage</surname><given-names>KB</given-names></name><name><surname>Kim</surname><given-names>JB</given-names></name><name><surname>Knight</surname><given-names>JR</given-names></name><name><surname>Lanza</surname><given-names>JR</given-names></name><name><surname>Leamon</surname><given-names>JH</given-names></name><name><surname>Lefkowitz</surname><given-names>SM</given-names></name><name><surname>Lei</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Lohman</surname><given-names>KL</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Makhijani</surname><given-names>VB</given-names></name><name><surname>McDade</surname><given-names>KE</given-names></name><name><surname>McKenna</surname><given-names>MP</given-names></name><name><surname>Myers</surname><given-names>EW</given-names></name><name><surname>Nickerson</surname><given-names>E</given-names></name><name><surname>Nobile</surname><given-names>JR</given-names></name><name><surname>Plant</surname><given-names>R</given-names></name><name><surname>Puc</surname><given-names>BP</given-names></name><name><surname>Ronan</surname><given-names>MT</given-names></name><name><surname>Roth</surname><given-names>GT</given-names></name><name><surname>Sarkis</surname><given-names>GJ</given-names></name><name><surname>Simons</surname><given-names>JF</given-names></name><name><surname>Simpson</surname><given-names>JW</given-names></name><name><surname>Srinivasan</surname><given-names>M</given-names></name><name><surname>Tartaro</surname><given-names>KR</given-names></name><name><surname>Tomasz</surname><given-names>A</given-names></name><name><surname>Vogt</surname><given-names>KA</given-names></name><name><surname>Volkmer</surname><given-names>GA</given-names></name><name><surname>Wang</surname><given-names>SH</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Weiner</surname><given-names>MP</given-names></name><name><surname>Yu</surname><given-names>P</given-names></name><name><surname>Begley</surname><given-names>RF</given-names></name><name><surname>Rothberg</surname><given-names>JM</given-names></name></person-group><article-title>Genome sequencing in microfabricated high-density picolitre reactors</article-title><source>Nature</source><year>2005</year><volume>437</volume><fpage>376</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">16056220</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Darling</surname><given-names>AC</given-names></name><name><surname>Mau</surname><given-names>B</given-names></name><name><surname>Blattner</surname><given-names>FR</given-names></name><name><surname>Perna</surname><given-names>NT</given-names></name></person-group><article-title>Mauve: multiple alignment of conserved genomic sequence with rearrangements</article-title><source>Genome Res</source><year>2004</year><volume>14</volume><fpage>1394</fpage><lpage>1403</lpage><pub-id pub-id-type="pmid">15231754</pub-id><pub-id pub-id-type="doi">10.1101/gr.2289704</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowden</surname><given-names>MG</given-names></name><name><surname>Visai</surname><given-names>L</given-names></name><name><surname>Longshaw</surname><given-names>CM</given-names></name><name><surname>Holland</surname><given-names>KT</given-names></name><name><surname>Speziale</surname><given-names>P</given-names></name><name><surname>Hook</surname><given-names>M</given-names></name></person-group><article-title>Is the GehD lipase from <italic>Staphylococcus epidermidis </italic>a collagen binding adhesin</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>43017</fpage><lpage>43023</lpage><pub-id pub-id-type="pmid">12218064</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M207921200</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jose</surname><given-names>J</given-names></name><name><surname>Christians</surname><given-names>S</given-names></name><name><surname>Rosenstein</surname><given-names>R</given-names></name><name><surname>Gotz</surname><given-names>F</given-names></name><name><surname>Kaltwasser</surname><given-names>H</given-names></name></person-group><article-title>Cloning and expression of various staphylococcal genes encoding urease in <italic>Staphylococcus carnosus</italic></article-title><source>FEMS Microbiol Lett</source><year>1991</year><volume>64</volume><fpage>277</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">1884984</pub-id><pub-id pub-id-type="doi">10.1111/j.1574-6968.1991.tb04675.x</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>MS</given-names></name></person-group><article-title>Mutants in the CtpA copper transportingP-type ATPase reduce virulence of <italic>Listeria monocytogenes</italic></article-title><source>Microb Pathog</source><year>1997</year><volume>22</volume><fpage>67</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">9049996</pub-id><pub-id pub-id-type="doi">10.1006/mpat.1996.0092</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bendtsen</surname><given-names>JD</given-names></name><name><surname>Kiemer</surname><given-names>L</given-names></name><name><surname>Fausboll</surname><given-names>A</given-names></name><name><surname>Brunak</surname><given-names>S</given-names></name></person-group><article-title>Non-classical protein secretion in bacteria</article-title><source>BMC Microbiol</source><year>2005</year><volume>5</volume><fpage>58</fpage><pub-id pub-id-type="pmid">16212653</pub-id><pub-id pub-id-type="doi">10.1186/1471-2180-5-58</pub-id></citation></ref><ref id="B40"><citation citation-type="other"><article-title>The network on antimicrobial resistance in <italic>Staphylococcus aureus</italic></article-title><ext-link ext-link-type="uri" xlink:href="http://www.narsa.net/"/></citation></ref><ref id="B41"><citation citation-type="other"><article-title>Clinical and laboratory standards institute (CLSI). Performance standards for antimicrobial susceptibility testing</article-title><source>Performance standards for antimicrobial susceptibility testing; Sixteenth informational supplement M100-S16 (M7) Table 2C MIC interpretive standards (&#x003bc;g/ml) for Staphylococcus aureus Wayne, PA: CLSI</source><year>2006</year></citation></ref><ref id="B42"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Sambrook</surname><given-names>J</given-names></name><name><surname>Russell</surname><given-names>DW</given-names></name></person-group><source>Molecular cloning: a laboratory manual</source><year>2001</year><edition>3</edition><publisher-name>Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press</publisher-name></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>B</given-names></name><name><surname>Wentland</surname><given-names>MA</given-names></name><name><surname>Ricafrente</surname><given-names>JY</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name></person-group><article-title>A "double adaptor" method for improved shotgun library construction</article-title><source>Anal Biochem</source><year>1996</year><volume>236</volume><fpage>107</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">8619474</pub-id><pub-id pub-id-type="doi">10.1006/abio.1996.0138</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Havlak</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Durbin</surname><given-names>KJ</given-names></name><name><surname>Egan</surname><given-names>A</given-names></name><name><surname>Ren</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>XZ</given-names></name><name><surname>Weinstock</surname><given-names>GM</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name></person-group><article-title>The Atlas genome assembly system</article-title><source>Genome Res</source><year>2004</year><volume>14</volume><fpage>721</fpage><lpage>732</lpage><pub-id pub-id-type="pmid">15060016</pub-id><pub-id pub-id-type="doi">10.1101/gr.2264004</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delcher</surname><given-names>AL</given-names></name><name><surname>Harmon</surname><given-names>D</given-names></name><name><surname>Kasif</surname><given-names>S</given-names></name><name><surname>White</surname><given-names>O</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><article-title>Improved microbial identification with GLIMMER</article-title><source>Nucleic Acids Res</source><year>1999</year><volume>27</volume><fpage>4636</fpage><lpage>4641</lpage><pub-id pub-id-type="pmid">10556321</pub-id><pub-id pub-id-type="doi">10.1093/nar/27.23.4636</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lukashin</surname><given-names>A</given-names></name><name><surname>Borodovsky</surname><given-names>M</given-names></name></person-group><article-title>GeneMark.hmm: new solutions for gene finding</article-title><source>Nucleic Acids Res</source><year>1998</year><volume>26</volume><fpage>1107</fpage><lpage>1115</lpage><pub-id pub-id-type="pmid">9461475</pub-id><pub-id pub-id-type="doi">10.1093/nar/26.4.1107</pub-id></citation></ref><ref id="B47"><citation citation-type="other"><article-title>Genboree</article-title><ext-link ext-link-type="uri" xlink:href="http://www.genboree.org/"/></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McLeod</surname><given-names>MP</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Karpathy</surname><given-names>SE</given-names></name><name><surname>Gioia</surname><given-names>J</given-names></name><name><surname>Highlander</surname><given-names>SK</given-names></name><name><surname>Fox</surname><given-names>GE</given-names></name><name><surname>McNeill</surname><given-names>TZ</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Muzny</surname><given-names>D</given-names></name><name><surname>Jacob</surname><given-names>LS</given-names></name><name><surname>Hawes</surname><given-names>AC</given-names></name><name><surname>Sodergren</surname><given-names>E</given-names></name><name><surname>Gill</surname><given-names>R</given-names></name><name><surname>Hume</surname><given-names>J</given-names></name><name><surname>Morgan</surname><given-names>M</given-names></name><name><surname>Fan</surname><given-names>G</given-names></name><name><surname>Amin</surname><given-names>AG</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Hong</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>XJ</given-names></name><name><surname>Walker</surname><given-names>DH</given-names></name><name><surname>Weinstock</surname><given-names>GM</given-names></name></person-group><article-title>Complete genome sequence of <italic>Rickettsia typhi </italic>and comparison with sequences of other rickettsiae</article-title><source>J Bacteriol</source><year>2004</year><volume>186</volume><fpage>5842</fpage><lpage>5855</lpage><pub-id pub-id-type="pmid">15317790</pub-id><pub-id pub-id-type="doi">10.1128/JB.186.17.5842-5855.2004</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zdobnov</surname><given-names>EM</given-names></name><name><surname>Apweiler</surname><given-names>R</given-names></name></person-group><article-title>InterProScan &#x02013; an integration platform for the signature-recognition methods in InterPro</article-title><source>Bioinformatics</source><year>2001</year><volume>17</volume><fpage>847</fpage><lpage>848</lpage><pub-id pub-id-type="pmid">11590104</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/17.9.847</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>T</given-names></name><name><surname>Luban</surname><given-names>S</given-names></name><name><surname>Kihara</surname><given-names>D</given-names></name></person-group><article-title>Enhanced automated function prediction using distantly related sequences and contextual association by PFP</article-title><source>Protein Sci</source><year>2006</year><volume>15</volume><fpage>1550</fpage><lpage>1556</lpage><pub-id pub-id-type="pmid">16672240</pub-id><pub-id pub-id-type="doi">10.1110/ps.062153506</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gardy</surname><given-names>JL</given-names></name><name><surname>Laird</surname><given-names>MR</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Rey</surname><given-names>S</given-names></name><name><surname>Walsh</surname><given-names>CJ</given-names></name><name><surname>Ester</surname><given-names>M</given-names></name><name><surname>Brinkman</surname><given-names>FSL</given-names></name></person-group><article-title>PSORTb v.2.0: Expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis</article-title><source>Bioinformatics</source><year>2004</year><volume>21</volume><fpage>617</fpage><lpage>623</lpage><pub-id pub-id-type="pmid">15501914</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/bti057</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dodd</surname><given-names>IB</given-names></name><name><surname>Egan</surname><given-names>JB</given-names></name></person-group><article-title>The prediction of helix-turn-helix DNA-binding regions in proteins</article-title><source>Protein Eng</source><year>1988</year><volume>2</volume><fpage>174</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">3237681</pub-id><pub-id pub-id-type="doi">10.1093/protein/2.3.174</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rawlings</surname><given-names>ND</given-names></name><name><surname>Morton</surname><given-names>FR</given-names></name><name><surname>Barrett</surname><given-names>AJ</given-names></name></person-group><article-title>MEROPS: the peptidase database</article-title><source>Nucleic Acids Res</source><year>2006</year><volume>34</volume><fpage>D270</fpage><lpage>D272</lpage><pub-id pub-id-type="pmid">16381862</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkj089</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saier</surname><given-names>MH</given-names><suffix>Jr</suffix></name><name><surname>Tran</surname><given-names>CV</given-names></name><name><surname>Barabote</surname><given-names>RD</given-names></name></person-group><article-title>TCDB: the Transporter Classification Database for membrane transport protein analyses and information</article-title><source>Nucleic Acids Res</source><year>2006</year><fpage>D181</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">16381841</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkj001</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bengert</surname><given-names>P</given-names></name><name><surname>Dandekar</surname><given-names>T</given-names></name></person-group><article-title>Riboswitch finder &#x02013; a tool for identification of riboswitch RNAs</article-title><source>Nucleic Acids Res</source><year>2004</year><volume>32</volume><fpage>W154</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15215370</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkh352</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abreu-Goodger</surname><given-names>C</given-names></name><name><surname>Merino</surname><given-names>E</given-names></name></person-group><article-title>RibEx: a web server for locating riboswitches and other conserved bacterial regulatory elements</article-title><source>Nucleic Acids Res</source><year>2005</year><volume>33</volume><fpage>W690</fpage><lpage>W692</lpage><pub-id pub-id-type="pmid">15980564</pub-id><pub-id pub-id-type="doi">10.1093/nar/gki445</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>JD</given-names></name><name><surname>Higgins</surname><given-names>DG</given-names></name><name><surname>Gibson</surname><given-names>TJ</given-names></name></person-group><article-title>CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice</article-title><source>Nucleic Acids Res</source><year>1994</year><volume>22</volume><fpage>4673</fpage><lpage>4680</lpage><pub-id pub-id-type="pmid">7984417</pub-id><pub-id pub-id-type="doi">10.1093/nar/22.22.4673</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tamura</surname><given-names>K</given-names></name><name><surname>Dudley</surname><given-names>J</given-names></name><name><surname>Nei</surname><given-names>M</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name></person-group><article-title>MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0</article-title><source>Mol Biol Evol</source><year>2007</year><volume>24</volume><fpage>1596</fpage><lpage>1599</lpage><pub-id pub-id-type="pmid">17488738</pub-id><pub-id pub-id-type="doi">10.1093/molbev/msm092</pub-id></citation></ref></ref-list></back></article> 